• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AZT
Click for more information
0.00% $1.15

AZURE HEALTH TECHNOLOGY LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
AZT Interim CEO Appointment & Director ResignationPRICE SENSITIVE18/02/16
AZT Company Presentation29/01/16
AZT Chairman's Quarterly Review & Appendix 4CPRICE SENSITIVE29/01/16
AZT Receipt of NASDAQ Notice27/01/16
AZT Appendix 3B15/01/16
AZT REC*IT Passes Half a Million MilestonePRICE SENSITIVE17/12/15
AZT Clarification on NASDAQ Notice14/12/15
AZT Receipt of NASDAQ Notice11/12/15
AZT Change of Director's Interest Notice x602/12/15
AZT Cleansing Statement27/11/15
AZT Appendix 3B27/11/15
AZT Blue Nation Review TransactionPRICE SENSITIVE25/11/15
AZT New High School App Launched, Bigteams Powered by REC*ITPRICE SENSITIVE24/11/15
AZT New REC*IT FITNESS App Launched23/11/15
AZT Final Director's Interest Notice23/11/15
AZT Results of Annual General Meeting17/11/15
AZT Director Not Standing to Re-Election17/11/15
AZT AGM Presentation17/11/15
AZT Cleansing Statement12/11/15
AZT Appendix 3B12/11/15
AZT Change in substantial holding11/11/15
AZT Cleansing Statement05/11/15
AZT Appendix 3B05/11/15
AZT Form 20-F Annual Report02/11/15
AZT Reinstatement to Official QuotationPRICE SENSITIVE30/10/15
AZT Chairman's Quarterly Review & Appendix 4C30/10/15
AZT MOKO Prices U.S. Public Offering to Raise US$2.55m30/10/15
AZT SuspensionPRICE SENSITIVE29/10/15
AZT Trading HaltPRICE SENSITIVE27/10/15
AZT Notice of Annual General Meeting/Proxy Form16/10/15
AZT Market Upate - REC*IT 2.0 and SPEAKIESY Early ResultsPRICE SENSITIVE07/10/15
AZT Initial Director's Interest Notice x206/10/15
AZT Amended Annual Report to shareholders05/10/15
AZT Appendix 4G & Corporate Governance Statement30/09/15
AZT Annual Report to shareholders30/09/15
AZT Non-Executive Director Appointment24/09/15
AZT Non-Executive Director Appointment23/09/15
AZT Appendix 3B22/09/15
AZT Appendix 3B18/09/15
AZT Market Update - REC*IT 2.0 LaunchPRICE SENSITIVE17/09/15
AZT Preliminary Final ReportPRICE SENSITIVE31/08/15
AZT Chairman's Quarterly Review & Appendix 4CPRICE SENSITIVE31/07/15
AZT Change of Director's Interest Notice30/07/15
AZT Change of Director's Interest Notice23/07/15
AZT Appointment of Managing Editor of Blue Nation Review20/07/15
AZT Form F-3 Registration Statement15/07/15
AZT US$40m Form F-3 Filed with US SECPRICE SENSITIVE15/07/15
AZT Monthly Unique Visitor UpdatePRICE SENSITIVE06/07/15
AZT Ceasing to be a substantial holder26/06/15
AZT Change in substantial holding26/06/15
AZT Change of Director's Interest Notice26/06/15
AZT Cleansing Statement26/06/15
AZT Appendix 3B26/06/15
AZT Change in substantial holding23/06/15
AZT Change of Director's Interest Notices - GM, IR & JW19/06/15
AZT Exercise of Listed Options Raises $6.8m19/06/15
AZT Appendix 3B19/06/15
AZT Appendix 3B03/06/15
AZT Blue Nation Review Growth & Engagement AnalysisPRICE SENSITIVE18/05/15
AZT Letter to Holders of Listed Options14/05/15
AZT MOKO Investor Presentation07/05/15
AZT Cleansing Statement07/05/15
AZT Appendix 3B07/05/15
AZT Cleansing Statement01/05/15
AZT Appendix 3B01/05/15
AZT Chairman's Quarterly Review & Appendix 4CPRICE SENSITIVE30/04/15
AZT MOKO Completes Agreement With BigTeams28/04/15
AZT Appendix 3B27/04/15
AZT Cleansing Statement13/04/15
AZT Appendix 3B13/04/15
AZT Final Director's Interest Notice13/04/15
AZT Non Executive Director Resignation13/04/15
AZT Appendix 3B10/04/15
AZT Initial Director's Interest Notice10/04/15
AZT New Exclusive Agreement with BigTeamsPRICE SENSITIVE07/04/15
AZT Appointment of Chief Operating Officer30/03/15
AZT Change of Director's Interest Notice27/03/15
AZT Appendix 3B23/03/15
AZTAppendix 3B23/03/15
AZT Non Executive Director Appointment20/03/15
AZT Appendix 3B13/03/15
AZT Appendix 3B02/03/15
AZT Half Yearly Results & Strategy Implementation Update27/02/15
AZT Half Yearly Report and AccountsPRICE SENSITIVE27/02/15
AZT Appendix 3B23/02/15
AZT Appendix 3B16/02/15
AZT Cleansing Statement13/02/15
AZT Appendix 3B13/02/15
AZT Paid Content Syndication Partnership with the New York PostPRICE SENSITIVE10/02/15
AZT New Exclusive Partnership with InnoSoft FusionPRICE SENSITIVE09/02/15
AZT Change in substantial holding05/02/15
AZT Appendix 3B05/02/15
AZT Change of Registered Office03/02/15
AZT Initial Director's Interest Notice03/02/15
AZT Chairman's Quarterly Review & Appendix 4CPRICE SENSITIVE30/01/15
AZT Director Appointment29/01/15
AZT MOKO Extends Agreement with IM Leagues28/01/15
AZT Market Update - Tagroom Success Launch15/01/15
AZT Appendix 3B24/12/14
AZT Appendix 3B24/12/14
AZT Interim CEO Appointment & Director Resignation
18/02/16PRICE SENSITIVE
AZT Company Presentation
29/01/16
AZT Chairman's Quarterly Review & Appendix 4C
29/01/16PRICE SENSITIVE
AZT Receipt of NASDAQ Notice
27/01/16
AZT Appendix 3B
15/01/16
AZT REC*IT Passes Half a Million Milestone
17/12/15PRICE SENSITIVE
AZT Clarification on NASDAQ Notice
14/12/15
AZT Receipt of NASDAQ Notice
11/12/15
AZT Change of Director's Interest Notice x6
02/12/15
AZT Cleansing Statement
27/11/15
AZT Appendix 3B
27/11/15
AZT Blue Nation Review Transaction
25/11/15PRICE SENSITIVE
AZT New High School App Launched, Bigteams Powered by REC*IT
24/11/15PRICE SENSITIVE
AZT New REC*IT FITNESS App Launched
23/11/15
AZT Final Director's Interest Notice
23/11/15
AZT Results of Annual General Meeting
17/11/15
AZT Director Not Standing to Re-Election
17/11/15
AZT AGM Presentation
17/11/15
AZT Cleansing Statement
12/11/15
AZT Appendix 3B
12/11/15
AZT Change in substantial holding
11/11/15
AZT Cleansing Statement
05/11/15
AZT Appendix 3B
05/11/15
AZT Form 20-F Annual Report
02/11/15
AZT Reinstatement to Official Quotation
30/10/15PRICE SENSITIVE
AZT Chairman's Quarterly Review & Appendix 4C
30/10/15
AZT MOKO Prices U.S. Public Offering to Raise US$2.55m
30/10/15
AZT Suspension
29/10/15PRICE SENSITIVE
AZT Trading Halt
27/10/15PRICE SENSITIVE
AZT Notice of Annual General Meeting/Proxy Form
16/10/15
AZT Market Upate - REC*IT 2.0 and SPEAKIESY Early Results
07/10/15PRICE SENSITIVE
AZT Initial Director's Interest Notice x2
06/10/15
AZT Amended Annual Report to shareholders
05/10/15
AZT Appendix 4G & Corporate Governance Statement
30/09/15
AZT Annual Report to shareholders
30/09/15
AZT Non-Executive Director Appointment
24/09/15
AZT Non-Executive Director Appointment
23/09/15
AZT Appendix 3B
22/09/15
AZT Appendix 3B
18/09/15
AZT Market Update - REC*IT 2.0 Launch
17/09/15PRICE SENSITIVE
AZT Preliminary Final Report
31/08/15PRICE SENSITIVE
AZT Chairman's Quarterly Review & Appendix 4C
31/07/15PRICE SENSITIVE
AZT Change of Director's Interest Notice
30/07/15
AZT Change of Director's Interest Notice
23/07/15
AZT Appointment of Managing Editor of Blue Nation Review
20/07/15
AZT Form F-3 Registration Statement
15/07/15
AZT US$40m Form F-3 Filed with US SEC
15/07/15PRICE SENSITIVE
AZT Monthly Unique Visitor Update
06/07/15PRICE SENSITIVE
AZT Ceasing to be a substantial holder
26/06/15
AZT Change in substantial holding
26/06/15
AZT Change of Director's Interest Notice
26/06/15
AZT Cleansing Statement
26/06/15
AZT Appendix 3B
26/06/15
AZT Change in substantial holding
23/06/15
AZT Change of Director's Interest Notices - GM, IR & JW
19/06/15
AZT Exercise of Listed Options Raises $6.8m
19/06/15
AZT Appendix 3B
19/06/15
AZT Appendix 3B
03/06/15
AZT Blue Nation Review Growth & Engagement Analysis
18/05/15PRICE SENSITIVE
AZT Letter to Holders of Listed Options
14/05/15
AZT MOKO Investor Presentation
07/05/15
AZT Cleansing Statement
07/05/15
AZT Appendix 3B
07/05/15
AZT Cleansing Statement
01/05/15
AZT Appendix 3B
01/05/15
AZT Chairman's Quarterly Review & Appendix 4C
30/04/15PRICE SENSITIVE
AZT MOKO Completes Agreement With BigTeams
28/04/15
AZT Appendix 3B
27/04/15
AZT Cleansing Statement
13/04/15
AZT Appendix 3B
13/04/15
AZT Final Director's Interest Notice
13/04/15
AZT Non Executive Director Resignation
13/04/15
AZT Appendix 3B
10/04/15
AZT Initial Director's Interest Notice
10/04/15
AZT New Exclusive Agreement with BigTeams
07/04/15PRICE SENSITIVE
AZT Appointment of Chief Operating Officer
30/03/15
AZT Change of Director's Interest Notice
27/03/15
AZT Appendix 3B
23/03/15
AZTAppendix 3B
23/03/15
AZT Non Executive Director Appointment
20/03/15
AZT Appendix 3B
13/03/15
AZT Appendix 3B
02/03/15
AZT Half Yearly Results & Strategy Implementation Update
27/02/15
AZT Half Yearly Report and Accounts
27/02/15PRICE SENSITIVE
AZT Appendix 3B
23/02/15
AZT Appendix 3B
16/02/15
AZT Cleansing Statement
13/02/15
AZT Appendix 3B
13/02/15
AZT Paid Content Syndication Partnership with the New York Post
10/02/15PRICE SENSITIVE
AZT New Exclusive Partnership with InnoSoft Fusion
09/02/15PRICE SENSITIVE
AZT Change in substantial holding
05/02/15
AZT Appendix 3B
05/02/15
AZT Change of Registered Office
03/02/15
AZT Initial Director's Interest Notice
03/02/15
AZT Chairman's Quarterly Review & Appendix 4C
30/01/15PRICE SENSITIVE
AZT Director Appointment
29/01/15
AZT MOKO Extends Agreement with IM Leagues
28/01/15
AZT Market Update - Tagroom Success Launch
15/01/15
AZT Appendix 3B
24/12/14
AZT Appendix 3B
24/12/14
refresh Created with Sketch. REFRESH
 

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.